You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Pediatric Acceptable Formulation of Amiodarone

    SBC: ACADEMIC PHARMACEUTICALS            Topic: N/A

    DESCRIPTION (provided by applicant): IV amiodarone is the first line therapy for life threatening ventricular as well as supraventricular arrhythmias. However, the Tween 80 and benzyl alcohol diluents limits the rate of administration severely, due to hypotension and myocardial contractile depression. These adverse toxicities contribute to the high mortality of cardiac arrest patients who have ma ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  2. SBIR Phase I: Low-cost Long-life Diamond Electrodes for Wastewater Treatment using Advanced Electrochemical Oxidation

    SBC: Advanced Diamond TechNologies, Inc.            Topic: NM

    This Small Business Innovation Research (SBIR) Phase I project will develop boron-doped ultrananocrystalline diamond (UNCD) electrodes for electrochemical treatment/destruction of recalcitrant organics in industrial wastewater via direct anodic oxidation. Boron-doped diamond (BDD) film electrodes have generated considerable interest due to their ability to readily mineralize complex waste streams. ...

    SBIR Phase I 2009 National Science Foundation
  3. SBIR Phase I: Development and Characterization of Bio-inert UNCD films for Implantable Devices to Eliminate Blood Clotting

    SBC: Advanced Diamond TechNologies, Inc.            Topic: BC

    This Small Business Innovation Research Phase I project will investigate UNCDýý, a nanocrystalline from of smooth, thin diamond, as an anti-thrombotic coating for implantable medical devices. One of the largest problem with implantable circulatory assist devices such as artificial hearts and vascular assist devices (VADs) is the need to treat patients with anticoagulants to avoid blood clots wit ...

    SBIR Phase I 2009 National Science Foundation
  4. STTR Phase I: Piezoelectric/diamond RF MEMS filters for mobile wireless applications

    SBC: Advanced Diamond TechNologies, Inc.            Topic: MM

    This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5). This Small Business Technology Transfer Phase I project will develop ultrananocrystalline diamond (UNCD?) as a high frequency structural layer for piezoelectrically-transduced micromachined RF resonators for MHz-GHz applications in wireless telecommunication systems. Diamond, in theory, is the ideal ...

    STTR Phase I 2009 National Science Foundation
  5. An Optical Sensor for Monitoring Odors at Agricultural Livestock Facilities

    SBC: AeroSurvey, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1998 Department of Agriculture
  6. Affordability-driven, Microwave Curing for Reversible Bonding of Composites

    SBC: AEROTECH ENGINEERING & RESEARCH CORP.            Topic: N/A

    Fastening and joining technology has lagged behind the progress that has been made in other areas of composites for advanced air vehicles. Aerotech proposes the development of reversible polymeric adhesive bonding of composites using variable frequency microwave energy. With this method, composites are bonded using Poly Ether Ether Ketone (a high temperature thermoplastic) which is cured using v ...

    SBIR Phase II 1998 Department of DefenseAir Force
  7. SBIR Phase I: Biodegradable Elastomers of Intravascular Drug Delivery

    SBC: VesselTek Biomedical LLC            Topic: BC

    This Small Business Innovation Research (SBIR) Phase I project will develop a cell and blood compatible, non-clotting drug-eluting prosthetic artery that can release, in a controlled manner, drugs or other small compounds that can inhibit scarring and clotting. Potential drug candidates will be loaded using various concentrations and conditions, in order to determine the release rate and dosing th ...

    SBIR Phase I 2009 National Science Foundation
  8. Controlled Release Vascular Grafts

    SBC: VesselTek Biomedical LLC            Topic: N/A

    DESCRIPTION (provided by applicant): In the United States, it is estimated that 8 million people suffer from peripheral artery disease (PAD). PAD is characterized by a gradual reduction in blood flow to the muscular arteries of the lower extremities caused by atherosclerosis. For those with severe PAD, lower extremity bypass grafting remains the predominant option for limb salvage. Although native ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  9. GPS-Based Animal Control System

    SBC: AgriTech Electronics, L.C.            Topic: N/A

    This is a Phase II proposal to continue the work begun by AgriTech Electronics, LC (AgriTech) on a GPS-based livestock control system. This system will exclude animals from areas, or contain them within defined boundaries, where it is impractical or inefficient to build fence to achieve this objective. These needs arise in a variety of contexts, including the exclusion of livestock from riparian a ...

    SBIR Phase I 1998 Department of Agriculture
  10. Development of a humanized anti-CD47 antibody for treatment of tissue ischemia.

    SBC: VASCULOX, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Nitric oxide (NO) is a critical regulator of cardiovascular physiology, coordinating the activities of the endothelium, the vessel wall and circulating cells to optimize the flow of blood and oxygen to tissues. Increasing the bioavailability of NO should provide therapeutic benefit in the treatment of many diseases ascribed to insufficient NO bioavailability. A ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government